Cites fatal cardiac events: FDA issues warning against domperidone; Drug is used off label as lactation enhancer

OB/GYN News, July 15, 2004 by Michele G. Sullivan

To reduce the availability of domperidone in this country, the FDA also sent letters to six U.S. pharmacies that import the drug for use in compounding. The letters warned that all drugs with domperidone are unapproved and violate the federal Food, Drug, and Cosmetic Act. These companies have been ordered to cease using domperidone in any preparation.

BY MICHELE G. SULLIVAN

Mid-Atlantic Bureau

COPYRIGHT 2004 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale